Twist Bioscience Co. (NASDAQ:TWST) Given Average Recommendation of Moderate Buy by Brokerages

Twist Bioscience Co. (NASDAQ:TWST – Free Report) has received an average recommendation of “Moderate Buy” from the six research firms that are currently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price objective among […]

Related Keywords

Canada ,Robertw Baird ,Dennis Cho ,Twist Bioscience Corporation ,Ci Investments Inc ,Twist Bioscience Co ,Goldman Sachs Group ,Twist Bioscience Company Profile ,First Horizon Advisors Inc ,Nasdaq ,Lazard Asset Management ,Barclays ,Twist Bioscience ,Free Report ,Marketbeat Ratings ,Bioscience Stock Down ,Financial Advisors ,Horizon Advisors ,Pension Plan Investment Board ,Asset Management ,Bioscience Corporation ,Twist Bioscience Daily ,